Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients - Takeaways - MDSpire

Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients

  • By

  • Marie A. Neu

  • Franziska Ortmüller

  • Abigale L. Robinson

  • Elias Dreismickenbecker

  • Henrike Otto

  • Lena Wypyrsczyk

  • Mareike Kühn

  • Michèle Wessa

  • Oliver Tüscher

  • Joerg Faber

  • February 26, 2026

  • 0 min

Share

  • 1

    Children undergoing cancer treatment face significant psychosocial stressors that can lead to mental health impairments.

  • 2

    Resilience is defined as the ability to maintain or recover mental health during and after exposure to substantial stressors.

  • 3

    Current resilience research in pediatric oncology lacks age-appropriate, disease-specific tools for assessing resilience during active treatment.

  • 4

    Most existing studies on resilience in childhood cancer rely on retrospective assessments, limiting insights into dynamic changes during treatment.

  • 5

    The development of the Mainz Resilience Assessment aims to fill the gap by providing a tool to evaluate resilience in young cancer patients.

Original Source(s)

Related Content